Brothers in Arms: Th17 and Treg Responses in Candida albicans Immunity

PLoS Pathogens

Volumn 10, Issue 12, 2014, Pages

  Whibley, Natasha ^a   Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL IMMUNITY; CANDIDIASIS; CELL FUNCTION; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; CANDIDA ALBICANS; IMMUNOLOGY;

CANDIDA ALBICANS;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; HUMANS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84919608022     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004456     Document Type: Article

References (60)

1. Hernández-Santos N, Gaffen SL, (2012) Th17 cells in immunity to Candida albicans. Cell Host Microbe 11: 425–435.
2. Huppler AR, Bishu S, Gaffen SL, (2012) Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res Ther 14: 217.
3. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, et al. (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65–68.
4. Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, et al. (2013) An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39: 676–686.
5. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, et al. (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299–311.
6. Ho AW, Shen F, Conti HR, Patel N, Childs EE, et al. (2010) IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol 185: 1063–1070.
7. Ferreira MC, Whibley N, Mamo AJ, Siebenlist U, Chan YR, et al. (2014) Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun 82: 1030–1035.
8. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A, (2010) IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 185: 5453–5462.
9. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, et al. (2012) The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS ONE 7: e46311.
10. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, et al. (2011) Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS ONE 6: e22770.
11. Pfaller MA, Diekema DJ, (2010) Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36: 1–53.
12. Huang W, Na L, Fidel PL, Schwarzenberger P, (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624–631.
13. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, et al. (2010) Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32: 681–691.
14. van de Veerdonk FL, Kullberg BJ, Verschueren IC, Hendriks T, van der Meer JW, et al. (2010) Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 34: 407–411.
15. Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, et al. (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361: 1727–1735.
16. Miossec P, Kolls JK, (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11: 763–776.
17. Huppler AR, Conti HR, Hernandez-Santos N, Darville T, Biswas PS, et al. (2014) Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol 192: 1745–1752.
18. Fulurija A, Ashman RB, Papadimitriou JM, (1996) Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 142: 3487–3496.
19. Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, et al. (2011) New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 4: 448–455.
20. Hernandez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, et al. (2013) Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol 6: 900–910.
21. Glocker E, Grimbacher B, (2010) Chronic mucocutaneous candidiasis and congenital susceptibility to Candida. Curr Opin Allergy Clin Immunol 10: 542–550.
22. Bär E, Gladiator A, Bastidas S, Roschitzki B, Acha-Orbea H, et al. (2012) A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J Immunol 188: 5636–5643.
23. Cua DJ, Tato CM, (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479–489.
24. Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S, (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190: 521–525.
25. Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, et al. (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34: 422–434.
26. Conti HR, Peterson AC, Brane L, Huppler AR, Hernández-Santos N, et al. (2014) Oral-resident ‘natural’ Th17 cells and γδ T cells control opportunistic Candida albicans infections. J Exp Med In press
27. Vignali DA, Collison LW, Workman CJ, (2008) How regulatory T cells work. Nat Rev Immunol 8: 523–532.
28. Josefowicz SZ, Lu LF, Rudensky AY, (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30: 531–564.
29. Fulton RB, Meyerholz DK, Varga SM, (2010) Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 185: 2382–2392.
30. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, et al. (2004) The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172: 3157–3166.
31. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502–507.
32. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, et al. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204: 2159–2169.
33. Lund JM, Hsing L, Pham TT, Rudensky AY, (2008) Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220–1224.
34. De Luca A, Montagnoli C, Zelante T, Bonifazi P, Bozza S, et al. (2007) Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 179: 5999–6008.
35. Bonifazi P, Zelante T, D'Angelo C, De Luca A, Moretti S, et al. (2009) Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol 2: 362–374.
36. Whibley N, Maccallum DM, Vickers MA, Zafreen S, Waldmann H, et al. (2014) Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol 44: 1069–1083.
37. Chen X, Oppenheim JJ, (2014) Th17 cells and Tregs: unlikely allies. J Leukoc Biol In press
38. Boyman O, Sprent J, (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12: 180–190.
39. Chen Y, Haines CJ, Gutcher I, Hochweller K, Blumenschein WM, et al. (2011) Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34: 409–421.
40. Zhou L, Chong MM, Littman DR, (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646–655.
41. Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, et al. (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38: 3274–3281.
42. Milner JD, Holland SM, (2013) The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol 13: 635–648.
43. Kekalainen E, Tuovinen H, Joensuu J, Gylling M, Franssila R, et al. (2007) A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 178: 1208–1215.
44. Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, et al. (2011) Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 208: 235–249.
45. Sharfe N, Dadi HK, Shahar M, Roifman CM, (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 94: 3168–3171.
46. MacCallum DM, Castillo L, Brown AJ, Gow NA, Odds FC, (2009) Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS ONE 4: e6420.
47. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, et al. (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695–2706.
48. Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, et al. (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172: 3712–3718.
49. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569–573.
50. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256–260.
51. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, et al. (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361: 1760–1767.
52. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, et al. (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205: 1551–1557.
53. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, et al. (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773–776.
54. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, et al. (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745–755.
55. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, et al. (2009) Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 124: 1289–1302.e1284.
56. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, et al. (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208: 1635–1648.
57. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, et al. (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365: 54–61.
58. de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, et al. (2010) Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89: 381–402.
59. Kisand K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, et al. (2010) Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 207: 299–308.
60. Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, et al. (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207: 291–297.